| Study of FLOMAX® Versus Placebo in Female Patients With Lower Urinary Tract Symptoms (LUTS) With a Significant Component of Voiding Symptoms (NCT02244281) | Boehringer Ingelheim | 2001-05-01 |
| Postmarketing Surveillance Study With MOBEC® (NCT02182726) | Boehringer Ingelheim | 2001-05-01 |
| Efficacy and Safety of Different Doses of BIRB 796 BS in Patients With Active Rheumatoid Arthritis (NCT02209779) | Boehringer Ingelheim | 2001-05-01 |
| Efficacy and Safety of Tiotropium and Atrovent in Subjects With Chronic Obstructive Pulmonary Disease (COPD) (NCT02172469) | Boehringer Ingelheim | 2001-05-01 |
| Surveillance of Patients With Suspected Acute Myocardial Infarction That Receive Early Inhospital Thrombolysis With Metalyse (NCT02194153) | Boehringer Ingelheim | 2001-05-01 |
| Tiotropium (Spiriva) Rehabilitation Study (NCT00274521) | Boehringer Ingelheim | 2001-05-01 |
| Study to Compare the Pharmacokinetics of Dipyridamole in Three Different Asasantin Extended Release (ER) Formulations in Healthy Male and Female Volunteers (NCT02273518) | Boehringer Ingelheim | 2001-04-01 |
| Bioavailability of BIBR 1048 MS Single Doses With or Without Pantoprazole in Healthy Subjects (NCT02170805) | Boehringer Ingelheim | 2001-04-01 |
| Effect of Treatment With BIIL 284 BS on Exercise Endurance in Patients With Chronic Obstructive Pulmonary Disease (NCT02249247) | Boehringer Ingelheim | 2001-04-01 |
| Combivent® HFA-propelled Compared to CFC-propelled Metered Dose Inhaler in Patients With COPD (Chronic Obstructive Pulmonary Disease) (NCT02182869) | Boehringer Ingelheim | 2001-04-01 |
| Rollover Trial Safety and Tolerability of Combination Tipranavir and Ritonavir Use in HIV 1 Infected Subjects (NCT00146328) | Boehringer Ingelheim | 2001-04-01 |
| Study of Relative Bioavailability of Mobic Manufactured in China in Comparison With Mobic Manufactured in Germany in Chinese Healthy Volunteers (NCT02183142) | Boehringer Ingelheim | 2001-03-01 |
| SAFE-CRP: Structural Alterations and Function of Endothelium in Cardiovascular Risk Patients (NCT00274105) | Boehringer Ingelheim | 2001-03-01 |
| Lung Function Changes Following the Addition of Formoterol to Tiotropium in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT02242240) | Boehringer Ingelheim | 2001-03-01 |
| Trial to Compare the Efficacy and Safety of a Single Bolus of TNK-tPA (Tenecteplase, Metalyse®) With Accelerated Infusion of Rt-PA (Alteplase, Actilyse®) in Asian Patients With Acute Myocardial Infarction (NCT00148460) | Boehringer Ingelheim | 2001-03-01 |
| FLOMAX® Versus Placebo, in Male Patients With Acute Urinary Retention Related to Benign Prostatic Hyperplasia (BPH) (NCT02244294) | Boehringer Ingelheim | 2001-03-01 |
| Bioavailability of BIBR 953 ZW After Dose of BIBR 1048 MS (NCT02170792) | Boehringer Ingelheim | 2001-02-01 |
| Post-marketing Surveillance of Atrovent® Inhalets in Chronic Obstructive Pulmonary Disease (NCT02233894) | Boehringer Ingelheim | 2001-02-01 |
| Postmarketing Surveillance Study of Atrovent® Inhalation Solution in Chronic Obstructive Pulmonary Disease (NCT02238197) | Boehringer Ingelheim | 2001-02-01 |
| Effects of Tipranavir/Ritonavir on the Pharmacokinetic Characteristics of Triple Drug Nucleoside and Non-nucleoside Reverse Transcriptase Inhibitor Therapy in HIV-1-infected Subjects (NCT02251223) | Boehringer Ingelheim | 2001-02-01 |
| Post-marketing Surveillance of Atrovent® in Chronic Obstructive Pulmonary Disease (NCT02233881) | Boehringer Ingelheim | 2001-01-01 |
| Evolution of Pulse Pressure Following Initiation of Antihypertensive Therapy in Patients With Essential Arterial Hypertension (NCT02202525) | Boehringer Ingelheim | 2001-01-01 |
| Mechanisms of Dyspnea Relief During Exercise in COPD Patients Following Treatment With Tiotropium (Spiriva) (NCT00274027) | Boehringer Ingelheim | 2001-01-01 |
| Safety and Pharmacokinetics of BIRB 796 BS Tablets Administered to Healthy Human Subjects (NCT02209805) | Boehringer Ingelheim | 2001-01-01 |
| Comparative Pharmacokinetics and Pharmacodynamics of Tiotropium With Ipratropium or Placebo After 19 Days of Tiotropium Treatment (NCT02172781) | Boehringer Ingelheim | 2001-01-01 |
| Tolerability of BIBR 953 ZW IV and Bioavailability of BIBR 1048 Tablet and Solution in Healthy Males (NCT02170584) | Boehringer Ingelheim | 2001-01-01 |
| Observational Study of Meloxicam in Any Labeled Indication (NCT02182739) | Boehringer Ingelheim | 2001-01-01 |
| Postmarketing Surveillance Study of Anticholinergics - Prescribing Pattern and Therapeutic Long Term Value in Patients Suffering From Moderate or Severe Chronic Obstructive Pulmonary Disease (COPD) (NCT02238184) | Boehringer Ingelheim | 2001-01-01 |
| Efficacy and Safety of Ba679BR Powder Inhalation in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT02172807) | Boehringer Ingelheim | 2000-12-01 |
| A Comparison of the Effects of Tiotropium Inhalation qd and Salmeterol Inhalation Bid on Arterial Blood Gases. (NCT00274534) | Boehringer Ingelheim | 2000-12-01 |
| Meloxicam [Mobic] in Juvenile Rheumatoid Arthritis (JRA) (NCT00034853) | Boehringer Ingelheim | 2000-12-01 |
| Single Dose Escalation Study of 131I-Sibrotuzumab in Patients With Advanced or Metastatic Non-small Cell Lung Cancer (NCT02209727) | Boehringer Ingelheim | 2000-12-01 |
| Effect of Tiotropium on Airway Diameter in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT02172391) | Boehringer Ingelheim | 2000-11-01 |
| Post Marketing Surveillance (PMS) Study to Assess Safety and Efficacy of Micardis in Patients With Essential Hypertension (NCT02245464) | Boehringer Ingelheim | 2000-11-01 |
| Effect of Tiotropium (Spiriva) on Exercise Tolerance in COPD Patients (NCT00274508) | Boehringer Ingelheim | 2000-10-10 |
| Pharmacokinetics of Dipyridamole Administered as Aggrenox® (Dipyridamole Extended Release Plus Aspirin) Capsule Versus Dipyridamole Immediate Release Plus Aspirin Following Alteration of Stomach pH (NCT02251184) | Boehringer Ingelheim | 2000-10-01 |
| HandiHaler® vs. Metered Dose Inhaler (MDI) in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT02172404) | Boehringer Ingelheim | 2000-10-01 |
| Study of the Comparability of Ipratropium Bromide Hydrofluoroalkane (HFA)-134a Inhalation Aerosol to the Market Standard, Atrovent® Chlorofluorocarbon (CFC) Inhalation Aerosol, in Patients With Chronic Obstructive Pulmonary Disease (NCT02260011) | Boehringer Ingelheim | 2000-10-01 |
| Bioavailability of BIBR 953 ZW in Healthy Subjects (NCT02170766) | Boehringer Ingelheim | 2000-10-01 |
| BIBR 1048 in the Prevention of Venous Thromboembolism in Patients Undergoing Primary Elective Total Hip Replacement Surgery (NCT02170701) | Boehringer Ingelheim | 2000-10-01 |
| Trial to Determine the Comparability of Ipratropium Bromide Hydrofluoroalkane (HFA)-134a Inhalation Aerosol to ATROVENT® Chlorofluorocarbon (CFC) Inhalation Aerosol, in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT02236169) | Boehringer Ingelheim | 2000-10-01 |
| Safety, Tolerability and Pharmacokinetics of Increasing Doses of BIBN 4096 BS in Healthy Male and Female Volunteers (NCT02194335) | Boehringer Ingelheim | 2000-10-01 |
| Comparison of Safety and Efficacy of COMBIVENT HFA to COMBIVENT (CFC) in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT02194205) | Boehringer Ingelheim | 2000-10-01 |
| Pharmacokinetics of Tipranavir Soft Elastic Capsules (SEDDS) and Ritonavir and Their Effects on Cytochrome P-450 (3A4) in Healthy Volunteers (NCT02251132) | Boehringer Ingelheim | 2000-10-01 |
| A Confirmation Study of Combivent HFA Inhalation Aerosol in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT02182674) | Boehringer Ingelheim | 2000-10-01 |
| Study to Evaluate the Effect of ALNA® (Tamsulosin) on the Primary Symptoms of Benign Prostatic Hyperplasia (NCT02244268) | Boehringer Ingelheim | 2000-10-01 |
| Measure of the Long Term Influence of SPIRIVA® in Acute Respiratory Disorders (NCT00274014) | Boehringer Ingelheim | 2000-10-01 |
| Relative Bioavailability, Pharmacokinetics, Safety and Tolerability of BIIL 284 BS in Healthy Volunteers (NCT02265640) | Boehringer Ingelheim | 2000-10-01 |
| Comparison of Tiotropium Inhalation Capsules and Oxitropium Metered Dose Inhalator (MDI) in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT02172430) | Boehringer Ingelheim | 2000-09-01 |
| A One Year Double-blind Trial to Investigate the Efficacy and Safety of Meloxicam Oral Suspension in Juvenile Rheumatoid Arthritis (JRA/JIA) (NCT00279747) | Boehringer Ingelheim | 2000-09-01 |
| Observational Study to Assess a 6-months Treatment With Gladem (NCT02231268) | Boehringer Ingelheim | 2000-09-01 |
| Efficacy and Safety of Telmisartan in Hypertensive Patients With Mild/Moderate or Severe Renal Impairment or Requiring Hemodialysis (NCT02178306) | Boehringer Ingelheim | 2000-09-01 |
| Single Dose Followed by Maintenance Dose Tolerance Study of BIIR 561 CL in Healthy Elderly Male and Female Volunteers (NCT02223507) | Boehringer Ingelheim | 2000-08-01 |
| Bioequivalence Between WE 941 OD and Brotizolam (Lendormin®) Taken With Water in Healthy Adult Males (NCT02218645) | Boehringer Ingelheim | 2000-08-01 |
| Effects of Telmisartan by Ambulatory Blood Pressure Monitoring (ABPM) in Chinese Patients With Mild to Moderate Essential Hypertension (NCT02206659) | Boehringer Ingelheim | 2000-08-01 |
| Efficacy and Safety of Telmisartan and Losartan in Primary Hypertension (NCT02269176) | Boehringer Ingelheim | 2000-07-01 |
| Bioequivalence Between WE 941 OD and Brotizolam (Lendormin®) in Healthy Adult Males (NCT02218658) | Boehringer Ingelheim | 2000-07-01 |
| Mechanism of Dipyridamole Action in Platelets: in Vivo Study With Healthy Volunteers (NCT02226926) | Boehringer Ingelheim | 2000-07-01 |
| Tiotropium in Combination With Concomitant Cimetidine or Ranitidine in Healthy Male and Female Subjects (NCT02172417) | Boehringer Ingelheim | 2000-07-01 |
| The Effect of Sifrol® on Tremor and Depression in Patients With Idiopathic Parkinson's Disease (NCT02231294) | Boehringer Ingelheim | 2000-07-01 |
| A Trial on Efficacy and Safety of Full Dose Tenecteplase Combined With Unfractionated Heparin (UFH) or Enoxaparin in Acute Myocardial Infarction (AMI) in the Prehospital Setting (NCT02181998) | Boehringer Ingelheim | 2000-07-01 |
| Evaluation of the Effects of Pharmaton Tablets on Mental Performance and Physical Fatigue in Nurses Working Night Shift (NCT02199847) | Boehringer Ingelheim | 2000-06-01 |
| A Study to Investigate the Procoagulant Effect of Tenecteplase (TNK-tPA), Alteplase (Rt-PA) and Streptokinase (SK) Administered to Patients With Acute Myocardial Infarction (AMI) (NCT02182011) | Boehringer Ingelheim | 2000-05-01 |
| Observation of Therapy With Micardis® (Telmisartan) in Patients With Essential Hypertension in Hospitals (NCT02238262) | Boehringer Ingelheim | 2000-05-01 |
| A Trial Comparing MICARDIS® (Telmisartan) and COZAAR® / LORZAAR® (Losartan) in Patients With Mild-to-Moderate Hypertension Using Ambulatory Blood Pressure Monitoring (ABPM) (NCT02200653) | Boehringer Ingelheim | 2000-05-01 |
| Effect of BIIL 284 BS on the Pharmacokinetics of Theophylline in Healthy Male Volunteers (NCT02273440) | Boehringer Ingelheim | 2000-05-01 |
| 12-week Treatment With Inhaled Tiotropium (18 mcg Once Daily) on Lung Function and Static Lung Volumes in Stable, Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) Patients. Correlation to Dyspnoea Scales (NCT02172378) | Boehringer Ingelheim | 2000-05-01 |
| Effect of Meloxicam Tablets on Bleeding Time in Healthy Subjects (NCT02183155) | Boehringer Ingelheim | 2000-05-01 |
| Full Dose Tenecteplase (TNK-tPA) Together With Heparin Sodium, Full Dose Tenecteplase With Enoxaparin, Half Dose Tenecteplase Together With Abciximab and Heparin Sodium in Patients With Acute Myocardial Infarction (AMI) (NCT02181985) | Boehringer Ingelheim | 2000-05-01 |
| Porfiromycin Used as an Adjuvant to Radiation Therapy in Postoperative Head and Neck Cancer Patients (NCT02183246) | Boehringer Ingelheim | 2000-05-01 |
| Epinastine + Pseudoephedrine SR (Slow Release) Versus Epinastine Alone in Patients With Perennial Allergic Rhinitis (NCT02182518) | Boehringer Ingelheim | 2000-05-01 |
| Postmarketing Surveillance Study of Atrovent® Inhalets in Chronic Obstructive Pulmonary Disease (NCT02238171) | Boehringer Ingelheim | 2000-04-01 |
| Tolerability and Pharmacokinetics of BIIB 722 CL Drinking Solution and of BIIB 722 CL Filmcoated Tablet in Healthy Subjects (NCT02227030) | Boehringer Ingelheim | 2000-04-01 |
| Study to Evaluate the Effect of Multiple Doses of BIIL 284 BS on the Pharmacokinetics of Prednisone in Healthy Male Subjects (NCT02268149) | Boehringer Ingelheim | 2000-04-01 |
| Comparison of Pharmacokinetics of Dipyridamole in Asasantin Extended Release (ER) and in a Combination of Persantin Immediate Release Tablets and ASA Tablets in Healthy Subjects (NCT02273505) | Boehringer Ingelheim | 2000-04-01 |
| Postmarketing Surveillance Study of Berotec® N 100 µg Metered-dose Inhaler in Chronic Obstructive Respiratory Tract Disease (NCT02244216) | Boehringer Ingelheim | 2000-04-01 |
| Telmisartan Compared With Enalapril in Elderly Patients With Blood Hypertension (NCT02177461) | Boehringer Ingelheim | 2000-04-01 |
| Pharmacokinetics of Simvastatin and Its Metabolite Simvastatin Acid With and Without Concomitant Administration of Telmisartan in Healthy Subjects (NCT02187536) | Boehringer Ingelheim | 2000-04-01 |
| Safety, Pharmacokinetics and Pharmacodynamics of BIRB 796 BS Tablets Administered to Healthy Human Subjects (NCT02211157) | Boehringer Ingelheim | 2000-03-01 |
| Pharmacokinetics, Safety and Tolerability of BIIL 284 BS in Patients With Hepatic Impairment in Comparison to Healthy Volunteers (NCT02265627) | Boehringer Ingelheim | 2000-03-01 |
| Metamizol for the Treatment of Neoplastic Chronic Pain (NCT02181920) | Boehringer Ingelheim | 2000-03-01 |
| Telmisartan in Mild to Moderate Hypertensive Patients (NCT02260089) | Boehringer Ingelheim | 2000-03-01 |
| Study to Determine the Ability of Seresis to Act as a Skin Protection Agent in Healthy Young Female Volunteers (NCT02191813) | Boehringer Ingelheim | 2000-03-01 |
| Pharmacological Study on Absorption of WE 941 OD Tablets in Japanese Healthy Male Volunteers (NCT02218671) | Boehringer Ingelheim | 2000-03-01 |
| A Trial Comparing MICARDIS® (Telmisartan) and COZAAR® (Losartan) in Patients With Mild-to-Moderate Hypertension Using Ambulatory Blood Pressure Monitoring (ABPM) (NCT02200640) | Boehringer Ingelheim | 2000-03-01 |
| Study to Determine Tolerability of Single Increasing Dose of BIBN 4096 BS in Healthy Male and Female Volunteers (NCT02194348) | Boehringer Ingelheim | 2000-02-01 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ESR 1150 CL in Healthy Subjects (NCT02209688) | Boehringer Ingelheim | 2000-02-01 |
| Tolerability of Asasantin in Healthy Female and Male Subjects (NCT02269228) | Boehringer Ingelheim | 2000-02-01 |
| Effect of Single Oral Dose BIRB 796 BS on Endotoxin-induced Inflammatory Responses in Healthy Human Subjects (NCT02211170) | Boehringer Ingelheim | 2000-02-01 |
| Effect of Different Food Compositions on Bioavailability of BIIL 284 BS in Healthy Male Volunteers (NCT02273427) | Boehringer Ingelheim | 2000-02-01 |
| Intravenous BIBH 1 in Patients With Metastatic Colorectal Cancer (NCT02198274) | Boehringer Ingelheim | 2000-02-01 |
| Telmisartan Plus Hydrochlorothiazide in Subjects With Mild-to-moderate Hypertension Who Failed to Respond to Telmisartan Monotherapy (NCT02177500) | Boehringer Ingelheim | 2000-01-01 |
| Single Increasing Doses of BIII 890 CL in Healthy Young Male Volunteers and in Healthy Elderly Male and Female Volunteers (NCT02269215) | Boehringer Ingelheim | 2000-01-01 |
| Pharmacodynamics, Preliminary Pharmacokinetics and Tolerability of BIBB 1464 (Tablet) in Hyperlipemic Healthy Male Subjects (NCT02229773) | Boehringer Ingelheim | 2000-01-01 |
| Telmisartan With or Without Hydrochlorothiazide (HCTZ) Compared With Losartan With or Without HCTZ in Mild to Moderate Hypertensive Patients (NCT02172586) | Boehringer Ingelheim | 2000-01-01 |
| Effects of Acetylsalicylic Acid Compared With the Combination of Acetylsalicylic Acid + Modified-release Dipyridamole on Serum Thromboxane B2 Formation and Platelet Aggregation in Healthy Volunteers (NCT02268773) | Boehringer Ingelheim | 2000-01-01 |
| Post-marketing Surveillance of Ventilat® Metered Dose Inhaler in Chronic Obstructive Bronchitis (NCT02233920) | Boehringer Ingelheim | 2000-01-01 |
| Pharmacokinetics, Safety and Efficacy of BIIL 284 BS in Patients With Rheumatoid Arthritis (RA) (NCT02247375) | Boehringer Ingelheim | 2000-01-01 |
| Observational Study in Patients Suffering From Benign Prostatic Hyperplasia Treated With Alpha-adrenergic Blockade (NCT02244307) | Boehringer Ingelheim | 2000-01-01 |
| Biodistribution Study With 186 Re-labelled Humanised Monoclonal Antibody BIWA 4 in Patients With Adenocarcinoma of the Breast (NCT02204046) | Boehringer Ingelheim | 2000-01-01 |